Bausch Health (BHC)
(Delayed Data from NYSE)
$8.08 USD
+0.07 (0.87%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $8.08 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Bausch Health (BHC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$7.79 | $12.00 | $3.00 | -2.75% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Bausch Health comes to $7.79. The forecasts range from a low of $3.00 to a high of $12.00. The average price target represents a decline of 2.75% from the last closing price of $8.01.
Analyst Price Targets (7 )
Broker Rating
Bausch Health currently has an average brokerage recommendation (ABR) of 3.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 3.14 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, one is Strong Buy, representing 14.29% of all recommendations. A month ago, Strong Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 0 |
ABR | 3.14 | 3.14 | 3.14 | 3.14 | 2.83 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/2/2024 | Piper Sandler | David Amsellem | Strong Sell | Strong Sell |
8/2/2024 | Not Identified | Not Identified | Hold | Hold |
7/10/2024 | Raymond James | Gary Nachman | Not Available | Hold |
5/3/2024 | Truist Securities | Leszek Sulewski | Hold | Hold |
4/1/2024 | Cowen & Co. | Michael Nedelcovych | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.14 |
ABR (Last week) | 3.14 |
# of Recs in ABR | 7 |
Average Target Price | $7.79 |
LT Growth Rate | NA |
Industry | Medical - Generic Drugs |
Industry Rank by ABR | 49 of 253 |
Current Quarter EPS Est: | 1.05 |
BHC FAQs
Bausch Health Cos Inc. (BHC) currently has an average brokerage recommendation (ABR) of 3.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Bausch Health Cos Inc. (BHC) is $7.79. The current on short-term price targets is based on 7 reports.
The forecasts for Bausch Health Cos Inc. (BHC) range from a low of $3 to a high of $12. The average price target represents a decline of $3.59 from the last closing price of $8.08.
The current DOWNSIDE for Bausch Health Cos Inc. (BHC) is 3.59%
Based on short-term price targets offered by seven analysts, the average price target for Bausch Health comes to $7.79. The forecasts range from a low of $3.00 to a high of $12.00. The average price target represents a decline of 2.75% from the last closing price of $8.01.